Guidance on Investigational New Drug Applications for Positron Emission Tomography Drugs; Availability

الملخص

The Food and Drug Administration (FDA) is announcing the availability of a guidance entitled "Investigational New Drug Applications for Positron Emission Tomography (PET) Drugs." The guidance is intended to assist manufacturers of PET drugs in submitting investigational new drug applications (INDs).